The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicity associated with ipilimumab and nivolumab (Ipi+Nivo) combination therapy in melanoma patients (pts) treated at a single-institution under an expanded-access program (EAP).
 
Claire Frances Friedman
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Pedram Navid-Azarbaijani
No Relationships to Disclose
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Castle Biosciences; Vaccinex
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Shonnette C. Campbell
No Relationships to Disclose
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I); Celgene (I)
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst)
 
Parisa Momtaz
No Relationships to Disclose
 
Nana A. Prempeh-Keteku
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michael Andrew Postow
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Yelena Shames
Honoraria - Novartis
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Paul B. Chapman
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Momenta Pharmaceuticals; Provectus
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Momenta Pharmaceuticals; Provectus
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb